Peter Fong's most recent trade in Rocket Pharmaceuticals Inc was a trade of 64,860 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rocket Pharmaceuticals Inc | Peter Fong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 64,860 | 64,860 | - | - | Stock Option (Right to Buy) | |
| Rocket Pharmaceuticals Inc | Peter Fong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 22,862 | 76,195 (0%) | 0% | 0 | Common Stock | |
| Rocket Pharmaceuticals Inc | Peter Fong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2025 | 30,000 | 53,333 (0%) | 0% | 0 | Common Stock | |
| Rocket Pharmaceuticals Inc | Peter Fong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2025 | 23,333 | 23,333 (0%) | 0% | 0 | Common Stock |